STOCK TITAN

DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. EVP & CFO John C. Fortson reported equity awards. He received 24,014 shares of Common Stock in the form of Restricted Stock Units that vest in one-third annual installments over three years ending August 10, 2029. He was also granted 104,200 stock options to buy Common Stock at an exercise price of $12.83 per share, vesting in similar one-third annual increments through August 10, 2029, and expiring on August 10, 2036.

Positive

  • None.

Negative

  • None.
Insider Fortson John C.
Role EVP & CFO
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2 104,200 $0.00 $0.00
Grant/Award Common Stock F1 24,014 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 104,200 shares (Direct); Common Stock — 24,014 shares (Direct)
Footnotes (2)
  1. F1. Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029.
  2. F2. Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.
Restricted Stock Units granted 24,014 shares RSU award vesting in one-third annual increments through August 10, 2029
Stock options granted 104,200 options Options to buy Common Stock granted to EVP & CFO John C. Fortson
Option exercise price $12.83 per share Exercise price equal to 110% of closing price on grant date
Option expiration date August 10, 2036 Expiration of 104,200 stock options granted to John C. Fortson
Vesting end date for awards August 10, 2029 Both RSUs and options vest in one-third annual increments through this date
Restricted Stock Units (RSUs) financial
"Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Stock Option financial
"Stock Option (Right to Buy) with an exercise price equal to 110% of the closing price..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"with an exercise price equal to 110% of the closing price of the Issuer's common stock..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"RSUs which vest in annual one-third (1/3) increments over a three-year (3) period..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What equity awards did XRAY EVP & CFO John C. Fortson receive on August 10, 2026?

John C. Fortson received 24,014 Restricted Stock Units and 104,200 stock options on August 10, 2026, as part of his equity compensation in DENTSPLY SIRONA Inc.

How do the new XRAY Restricted Stock Units for John C. Fortson vest?

The 24,014 RSUs awarded to John C. Fortson vest in annual one-third increments over a three-year period, with vesting ending on August 10, 2029, subject to the award terms.

What are the terms of John C. Fortson’s new XRAY stock options?

John C. Fortson received 104,200 stock options with an exercise price of $12.83 per share. These options vest in one-third annual installments through August 10, 2029 and expire on August 10, 2036.

Did John C. Fortson buy or sell any XRAY shares in this Form 4?

No open-market buys or sells were reported. The Form 4 shows equity awards to John C. Fortson: grants of RSUs and stock options that increase his direct holdings in DENTSPLY SIRONA Inc.

What is the exercise price of the new XRAY options granted to John C. Fortson?

The newly granted options have an exercise price of $12.83 per share, set at 110% of the closing price of DENTSPLY SIRONA Inc.’s common stock on the grant date.

When do John C. Fortson’s new XRAY stock options expire?

The 104,200 stock options granted to John C. Fortson expire on August 10, 2036, if not exercised earlier in accordance with their vesting and plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fortson John C.

(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NORTH CAROLINA 28277

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026A24,014(1)A$024,014D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$12.8308/10/2026A104,20008/10/2027(2)08/10/2036Common Stock104,200$0104,200D
Explanation of Responses:
1. Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029.
2. Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending August 10, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.
/s/ Jessica Nielsen Causey, Attorney-In-Fact for John C. Fortson08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)